Fulcrum Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of June 2024: 0.21x

Fulcrum Therapeutics Inc cash flow reinvestment rate. Fulcrum Therapeutics Inc (FULC) has a Cash Flow Reinvestment Rate of 0.21x as of June 2024, reinvesting $12.51 Million (capex $0.00 plus investments $-12.51 Million) from operating cash flow of $58.90 Million. Explore cash flow to debt ratio of Fulcrum Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.21x

(Capex + Investments) / Operating CF

Total Reinvested

$12.51 Million

Capex + Investments

Operating Cash Flow

$58.90 Million

USD

Capital Expenditures

$0.00

USD

Fulcrum Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)

Fulcrum Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Fulcrum Therapeutics Inc. For the full cash flow conversion analysis, see Fulcrum Therapeutics Inc cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow